SomaLogic Inc. (Nasdaq: SLGC) said Thursday evening that its $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB) is expected to be finalized Friday after shareholders for the Boulder biotech company voted this week to consummate the combination.
SomaLogic founder, CTO among shareholders opposing Standard BioTools merger – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
SomaLogic merger overcomes investor objections to win shareholder approval – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.
Investment firm Tikvah Management LLC plans to oppose SomaLogic Inc.’s (Nasdaq: SLGC) planned $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB), making Tikvah the second major investor to stake out a position against the deal in the last week or so.
Another investor opposes Somalogic merger – BizWest bizwest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizwest.com Daily Mail and Mail on Sunday newspapers.